Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Interest Coverage Ratio (2019 - 2022)

Historic Interest Coverage Ratio for Keros Therapeutics (KROS) over the last 4 years, with Q1 2022 value amounting to 24126.0.

  • Keros Therapeutics' Interest Coverage Ratio fell 5299.64% to 24126.0 in Q1 2022 from the same period last year, while for Dec 2022 it was 114790.0, marking a year-over-year decrease of 71450.34%. This contributed to the annual value of 114790.0 for FY2022, which is 71450.34% down from last year.
  • Keros Therapeutics' Interest Coverage Ratio amounted to 24126.0 in Q1 2022, which was down 5299.64% from 4866.0 recorded in Q4 2021.
  • Over the past 5 years, Keros Therapeutics' Interest Coverage Ratio peaked at 775.33 during Q3 2019, and registered a low of 24126.0 during Q1 2022.
  • For the 4-year period, Keros Therapeutics' Interest Coverage Ratio averaged around 9954.99, with its median value being 8444.0 (2020).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first crashed by 72338.74% in 2020, then soared by 6338.88% in 2021.
  • Quarter analysis of 4 years shows Keros Therapeutics' Interest Coverage Ratio stood at 775.33 in 2019, then tumbled by 1614.23% to 13291.0 in 2020, then soared by 63.39% to 4866.0 in 2021, then plummeted by 395.81% to 24126.0 in 2022.
  • Its Interest Coverage Ratio was 24126.0 in Q1 2022, compared to 4866.0 in Q4 2021 and 20197.0 in Q3 2021.